Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Current Assets (2022 - 2026)

HeartSciences (HSCS) has disclosed Current Assets for 4 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 33.32% year-over-year to $3.8 million, compared with a TTM value of $3.8 million through Oct 2025, down 33.32%, and an annual FY2025 reading of $2.2 million, down 70.47% over the prior year.
  • Current Assets was $3.8 million for Q4 2025 at HeartSciences, down from $4.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $8.7 million in Q1 2024 and bottomed at $1.8 million in Q4 2023.
  • Average Current Assets over 4 years is $4.2 million, with a median of $3.8 million recorded in 2025.
  • The sharpest move saw Current Assets surged 213.93% in 2024, then tumbled 70.47% in 2025.
  • Year by year, Current Assets stood at $4.1 million in 2022, then tumbled by 56.09% to $1.8 million in 2023, then soared by 213.93% to $5.7 million in 2024, then tumbled by 33.32% to $3.8 million in 2025.
  • Business Quant data shows Current Assets for HSCS at $3.8 million in Q4 2025, $4.4 million in Q3 2025, and $2.2 million in Q2 2025.